Clinical and Genetic Analysis of ROP — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Clinical and Genetic Analysis of ROP — Stella

Recruiting

Back to Retinopathy of Prematurity trials

Trial locations(5 sites)

United States

Stanford University, Palo Alto, California

University of Illinois Chicago, Chicago, Illinois

William Beaumont Hospital, Royal Oak, Michigan

Oregon Health & Science University, Portland, Oregon

University of Utah, Salt Lake City, Utah

Key details

Sponsor

Oregon Health and Science University

Collaborators

National Institutes of Health (NIH), U.S. National Science Foundation

Enrollment target

~2,000 participants

Started

July 2011

Primary completion

May 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Last updated April 2022

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov